trending Market Intelligence /marketintelligence/en/news-insights/trending/rPKzYflrUX4_yh7oFOQecw2 content esgSubNav
In This List

Intellia Therapeutics appoints president/CEO

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Intellia Therapeutics appoints president/CEO

John Leonard will become Intellia Therapeutics Inc.'s president and CEO on Jan. 1, 2018.

Leonard succeeds Nessan Bermingham, the company's founding president and CEO.

Leonard was most recently the executive vice president of research and development at the genome editing company.